首页> 外文期刊>China National Journal of New Gastroenterology >Histopathological study of hepatocellular carcinoma after transcatheter hepatic arterial embolization
【24h】

Histopathological study of hepatocellular carcinoma after transcatheter hepatic arterial embolization

机译:经导管肝动脉栓塞术后肝细胞癌的组织病理学研究

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS To study the histopathological changes in hepatocellular carcinoma (HCC) after transcatheter arterial embolization (TAE). METHODS Histopathological analysis was made in 39 cases of liver neoplasms after TAE and 11 cases of liver neoplasms after digital selective angiography (DSA), including pathological type, histological grade, necrotic degree, capsule, times of treatment, injured Vessel and lymphocyte infiltration. RESULTS Six cases with 100% necrosis, 14 cases with 30%-95% necrosis, 19 cases with 0%-5% necrosis after TAE and 11 cases without necrosis after DSA were found histologically. The necrosis was related to the pathological type, capsule, injured vessels, but not to the histological grade, time of treatment and lymphocyte infiltration of the liver neoplasms. CONCLUSIONS TAE is an effective therapy for the late-stage HCC. The encapsulated HCC is a preferable indicator for TAE.
机译:目的研究经导管动脉栓塞术(TAE)后肝细胞癌(HCC)的组织病理学变化。方法对39例TAE后肝肿瘤和11例数字选择性血管造影(DSA)后肝肿瘤进行组织病理学分析,包括病理类型,组织学分级,坏死程度,包膜,治疗时间,损伤的血管和淋巴细胞浸润。结果经组织学检查,发现TAE后坏死6例,占100%,坏死占30%-95%,19例占0%-5%,DSA后占11%。坏死与病理类型,包膜,受损血管有关,但与肝肿瘤的组织学等级,治疗时间和淋巴细胞浸润无关。结论TAE是晚期肝癌的有效治疗方法。封装的HCC是TAE的首选指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号